Supply Chain | December 14, 2022
BSV receives exclusive marketing and distribution right for NexoBrid in India
To focus on providing safer burn treatments for women and armed forces
To focus on providing safer burn treatments for women and armed forces
Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
The CSC shall hold Market Authorisation (MA) to sell SRL's BUSALFAN, API exclusively in China territory.
Analysis of Post-Marketing Safety Data Shows Consistent Findings with Safety Profile Reported in Clinical Trials of Edaravone
Company hires life science veteran Jessica Cao to join management team
Companies concluded memorandum of understanding that Takeda will continue to provide distribution support for the Moderna COVID-19 vaccines for a transitional period
The European Commission granted CMA in December 2021 for use of Nuvaxovid in individuals aged 18 and over, and Novavax filed for expanded CMA for use in adolescents aged 12 through 17 in March 2022
Subscribe To Our Newsletter & Stay Updated
